Literature DB >> 3215191

A rat model for imaging the effect of anti mouse antibody responses on the biodistribution of radiolabelled mouse monoclonal antibodies.

M V Pimm1, A C Perkins, L G Durrant, R W Baldwin.   

Abstract

Rats were injected both intradermally and intravenously with an IgG2b mouse monoclonal antibody (791T/36) and subsequently the biodistribution of intravenously injected 111In labelled antibody was examined by gamma camera imaging in these and control rats. The majority of pretreated rats showed a marked perturbation of the biodistribution of the radiolabelled antibody with a marked increase of the tracer in the liver. There was similar perturbation of the biodistribution of subsequently administered 111In labelled Fab fragment of the 791T/36 antibody and of another IgG2b monoclonal antibody. In contrast, there was little influence on the biodistribution of IgG2a or IgG1 monoclonal antibodies, indicating that the response in the rats was predominantly against the IgG2b isotype. This rat model system is amenable to examination of a number of aspects of the biological consequences of immune responses to foreign immunoglobulins relevant to their use for clinical imaging.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215191     DOI: 10.1007/bf00252398

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.

Authors:  M V Pimm; A C Perkins; N C Armitage; R W Baldwin
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

2.  A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.

Authors:  S M Andrew; A C Perkins; M V Pimm; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1988

3.  Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In.

Authors:  B A Brown; R D Comeau; P L Jones; F A Liberatore; W P Neacy; H Sands; B M Gallagher
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

4.  Human immune response to multiple injections of murine monoclonal IgG.

Authors:  D L Shawler; R M Bartholomew; L M Smith; R O Dillman
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

Authors:  R W Schroff; K A Foon; S M Beatty; R K Oldham; A C Morgan
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

6.  Antibodies against metal chelates.

Authors:  D T Reardan; C F Meares; D A Goodwin; M McTigue; G S David; M R Stone; J P Leung; R M Bartholomew; J M Frincke
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

7.  Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats.

Authors:  S Harkonen; J Stoudemire; R Mischak; L E Spitler; H Lopez; P Scannon
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

8.  The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M C Powell
Journal:  Nucl Med Commun       Date:  1988-04       Impact factor: 1.690

9.  Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.

Authors:  N S Courtenay-Luck; A A Epenetos; R Moore; M Larche; D Pectasides; B Dhokia; M A Ritter
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

  9 in total
  3 in total

1.  Mouse-specific antibody responses to a monoclonal antibody during repeated immunoscintigraphy investigations: comparison of antibody titres and imaging studies in a rat model.

Authors:  M V Pimm; A C Perkins; S J Gribben; A J Markham
Journal:  Eur J Nucl Med       Date:  1990

2.  Production of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imaging.

Authors:  L G Durrant; R A Robins; K C Ballantyne; E B Austin; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice.

Authors:  M V Pimm; S J Gribben
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.